Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$3.08 0.05 (1.65%) as of 4:30 Mon 5/13


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 175.81(M)
Last Volume: 97,895 Avg Vol: 97,624
52 Week Range: $1.32 - $4.2
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    : 5.4
Insider 6 Months    : 6.1
Insider 3/6 Months : 11.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,500 5,000 6,598 33,898
Total Buy Value $14,360 $15,253 $18,107 $61,191
Total People Bought 3 4 4 5
Total Buy Transactions 3 4 5 12
Total Shares Sold 25,000 25,000 25,000 45,000
Total Sell Value $76,500 $76,500 $76,500 $118,240
Total People Sold 1 1 1 2
Total Sell Transactions 2 2 2 4
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 517
  Page 12 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Czirr James C Director   –       •      –    2016-09-30 4 A $1.13 $95,586 I/I 84,589 3,425,498     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-09-30 4 A $1.13 $95,586 D/D 84,589 3,425,498     -
   Czirr James C Director   –       •      –    2016-06-30 4 A $1.47 $117,912 I/I 80,212 3,340,909     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-06-30 4 A $1.47 $117,912 D/D 80,212 3,340,909     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-04-20 4 S $1.59 $17,852 D/D (11,212) 3,260,697     -
   Czirr James C Director   –       •      –    2016-04-20 4 S $1.59 $17,852 I/I (11,212) 3,260,697     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-04-19 4 S $1.70 $56,287 D/D (33,100) 3,271,909     -
   Czirr James C Director   –       •      –    2016-04-19 4 S $1.70 $56,287 I/I (33,100) 3,271,909     -
   Greenberg Arthur Director   –       •      –    2016-01-05 4 B $1.72 $2,866 D/D 1,666 109,445 2.31     -
   Amelio Gilbert F Director   –       •      –    2015-11-30 4 S $2.10 $210 D/D (100) 119,961     -
   Traber Peter G President & CEO   •       •      –    2015-08-12 4 B $2.00 $4,000 D/D 2,000 107,333 2.73     -
   Freeman Kevin D Director   –       •      –    2015-06-01 4 B $2.70 $5,624 I/I 2,083 2,083 2.1     -
   Traber Peter G President & CEO   •       –      –    2015-06-01 4 B $2.53 $10,120 D/D 4,000 105,333 2.74     -
   Rubin Marc Director   –       •      –    2015-05-21 4 A $0.00 $0 D/D 2,768 48,581     -
   Amelio Gilbert F Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 15,921 120,061     -
   Rubin Marc Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 28,367 45,813     -
   Pressler Herman Paul Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 25,483 36,767     -
   Mauldin John F Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 25,483 42,669     -
   Prelack Steven Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 93,141 107,189     -
   Freeman Kevin D Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 10,531 27,643     -
   Martin Rod D Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 26,395 202,089     -
   Omenn Gilbert S Director   –       •      –    2015-04-08 4 A $0.00 $0 D/D 25,934 67,561     -
   Amelio Gilbert F Director   –       •      –    2015-04-07 4 A $0.00 $0 D/D 1,054 104,140     -
   Omenn Gilbert S Director   –       •      –    2015-04-07 4 A $0.00 $0 D/D 1,506 41,627     -
   Amelio Gilbert F Director   –       •      –    2015-03-12 4 A $0.00 $0 D/D 11,112 103,086     -
  517 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us